NEW YORK (GenomeWeb) – In an investor note released this week, investment bank Piper Jaffray projected solid growth in 2015 for Fluidigm's CyTOF mass spectrometry platform.

The projection is based primarily on what Piper Jaffray sees as growing academic acceptance of the platform, based on a significant increase in publications using the instrument. The firm noted as well that it believes placing additional instruments with existing customers represents a significant opportunity for Fluidigm.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.